Cardiac mechanotransduction: From sensing to disease and treatment

Trends in Pharmacological Sciences

Volumn 22, Issue 5, 2001, Pages 254-260

  Tavi, Pasi ^a   Laine, Mika ^b   Weckström, Matti ^a   Ruskoaho, Heikki ^a  

^a UNIVERSITY OF OULU   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

DRUG MECHANISM; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART WORK; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR AGENTS; HEART; HUMANS; MECHANORECEPTORS; SIGNAL TRANSDUCTION;

EID: 0035338924     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01679-5     Document Type: Review

References (67)

1. i in rat atrial myocytes: Role of increased troponin C affinity and stretch-activated ion channels
2. Stretch-activated and background non-selective cation channels in rat atrial myocytes
3. 2+ concentration after length changes in isolated rat ventricular trabeculae
4. Regulation of stretch-activated intracellular calcium transients by actin filaments
5. Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: Structure-response and binding analysis with analogs of levosimendan
6. The cardiac renin-angiotensin system. Conceptual, or a regulator of cardiac function
7. The human heart endothelin system: ET-1 synthesis storage, release and effect
8. 2+ transient that follow stretch of cardiac muscle: A possible explanation of the Anrep effect
9. 3 receptors that may modulate excitation-contraction coupling in the heart
10. Intracellular acidosis modulates the stretch-induced changes in E-C coupling of the rat atrium
11. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice
12. The α-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways
13. 2+-calmodulin-dependent protein kinase II on cardiac excitation-contraction coupling in ferret ventricular myocytes
14. 2+/calmodulin-dependent kinase II and calcineurin play critical roles in endothelin-1-induced cardiomyocyte hypertrophy
15. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo
16. 2+, calcineurin, and NF-AT
17. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy
18. Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy
19. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
20. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin
21. Calcineurin inhibitors and cardiac hypertrophy
22. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats
23. q
24. Expression of protein kinase Cβ in the heart causes hypertrophy in adult mice and sudden death in neonates
25. Transgenic overexpression of constitutively active protein kinase Cε causes concentric cardiac hypertrophy
26. Signaling in myocardial hypertrophy. Life after calcineurin?
27. 2-terminal kinase activation in the heart
28. Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals
29. Atrial natriuretic peptide: Synthesis, release, and metabolism
30. Natriuretic peptides
31. Functional consequences of altering myocardial adrenergic receptor signaling
32. Intracellular signalling through protein kinases in the heart
33. Mechanical stretch and angiotensin II differentially upregulate the renin-angiotensin system in cardiac myocytes in vitro
34. Endothelial cell storage and release of endothelin as a cardioregulatory mechanism
35. B receptor antagonist
36. Endothelin-1 is involved in stretch-induced early activation of B-type natriuretic peptide gene expression in atrial but not in ventricular myocytes
37. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice
38. The cellular and molecular response of cardiac myocytes to mechanical stress
39. GATA transcription factors and cardiac development
40. 2+ exchanger NCX1 is GATA factor dependent
41. Transcription factors of the NFAT family: Regulation and function
42. GATA-dependent recruitment of MEF2 proteins to target promoters
43. Combinatorial interactions regulating cardiac transcription
44. Transcriptional regulation during cardiac growth and development
45. Molecular mechanisms of myocardial remodeling
46. Brain natriuretic peptide in plasma, atria, and ventricles of vasopressin- and phenylephrine-infused conscious rats
47. Abnormalities of calcium cycling in the hypertrophied and failing heart
48. Length dependence of calcium- and force-transients in normal and failing human myocardium
49. Signaling pathways for cardiac hypertrophy and failure
50. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
51. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
52. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
53. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
54. The cardiac insufficiency bisoprolol study II (CIBIS II): A randomized trial
55. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
56. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system
57. Normalization of diastolic dysfunction in aortic stenosis late after valve replacement
58. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
59. Measurement and significance of circulating natriuretic peptides in cardiovascular disease
60. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction
61. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
62. A Drosophila mechanosensory transduction channel
63. + channel
64. Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training
65. Vasopeptidase inhibition: A new concept in blood pressure management
66. Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology
67. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial